Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Sleep Med. 2021 Feb 23;81:227–234. doi: 10.1016/j.sleep.2021.02.031

Table 3.

Prevalence of parent-reported anxiety among U.S. adolescents aged 13–17 years by medical conditions/behavioral conditions, and medications from the 2018 National Survey of Children’s Health (NSCH) dataset

No anxiety (n=9268, 85.30%)
 Anxiety (n=1597, 14.70%)
Characteristic n % n % X 2 p-value
Intellectual disability
No 9176 85.70 1531 14.30 <0.001
Yes 75 54.35 63 45.65
Brain injury
No 9181 85.52 1555 14.48 <0.001
Yes 55 60.44 36 39.56
Cerebral palsy
No 9216 85.39 1577 14.61 <0.001
Yes 20 60.61 13 39.39
Autism
No 9081 86.69 1394 13.31 <0.001
Yes 164 45.94 193 54.06
Behavioral problems
No 8892 87.87 1227 12.13 <0.001
Yes 346 48.66 365 51.34
ADD/ADHD
No 8342 89.03 1028 10.97 <0.001
Yes 812 59.75 547 40.25
Medications a
No 8471 92.41 696 7.59 <0.001
Yes 666 42.75 892 57.25
a

Medications taken for emotions, concentration, and/or behavior